S1P receptor mod News - LARVOL Sigma

S1P receptor mod

Welcome, Profile Billing Logout

«1 2...2 3 4 5 6 7 8 9 10 11 12 1314

||||||||||  Zeposia (ozanimod) / BMS
New P3 trial:  DAYBREAK: A Multi-Site, Open-Label Extension Trial of Oral RPC1063 in Relapsing Multiple Sclerosis (clinicaltrials.gov) -  Oct 22, 2015
P3, N=2350, Active, not recruiting,  Sponsor: Receptos, Inc.